# Novartis d.o.o. - Inspection Records

Source: https://www.keypedia.com/companies/novartis-doo/55471e35-a203-4edf-a4b9-fe1ad0bb16fd

> Inspection records and compliance data for Novartis d.o.o. in Menges, None. Access full analysis and detailed observations.

---

## Details

- Name: Novartis d.o.o.
- FEI Number: 3002807470
- City: Menges
- State: None
- Country Name: Slovenia
- Address Line 1: Kolodvorska Cesta 27
- Zip Code: None
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, IN VITRO BIOEQUIVALENCE OR BIOANALYTICAL TESTING

## Related Documents

- [483 - Novartis d.o.o. - 2023-07-21](https://www.keypedia.com/records/483/novartis-doo/69691f9f-8517-4912-812d-f0f1d44c99fa) — source: FDA, date: July 21, 2023
- [FDA Inspection 1215215 - Novartis d.o.o. - 2023-07-21](https://www.keypedia.com/records/fda_inspections/novartis-doo/be1f8dbf-ec85-4afd-ab0b-b5d25b8b0ca7) — source: FDA, date: July 21, 2023
- [FDA Inspection 1228827 - Novartis d.o.o. - 2022-09-21](https://www.keypedia.com/records/fda_inspections/novartis-doo/b39c80f5-1389-4298-b973-b1a35ed7a319) — classification: No Action Indicated (NAI), source: FDA, date: September 21, 2022
- [FDA Inspection 1155320 - Novartis d.o.o. - 2020-09-11](https://www.keypedia.com/records/fda_inspections/novartis-doo/4bf055c1-d709-40df-8e9a-cbe4a310aab7) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 11, 2020
- [FDA Inspection 1004338 - Novartis d.o.o. - 2017-02-13](https://www.keypedia.com/records/fda_inspections/novartis-doo/38a4ae18-3dc8-44f3-b5b6-f35e81024ba2) — classification: No Action Indicated (NAI), source: FDA, date: February 13, 2017
- [FDA Inspection 945699 - Novartis d.o.o. - 2015-09-18](https://www.keypedia.com/records/fda_inspections/novartis-doo/07caa49c-41cb-4df6-8475-3dfb733b37a8) — classification: No Action Indicated (NAI), source: FDA, date: September 18, 2015
- [FDA Inspection 807398 - Novartis d.o.o. - 2012-10-19](https://www.keypedia.com/records/fda_inspections/novartis-doo/1f734843-6120-4d60-a253-2ffff3ce7d17) — classification: No Action Indicated (NAI), source: FDA, date: October 19, 2012
- [FDA Inspection 605785 - Novartis d.o.o. - 2009-08-12](https://www.keypedia.com/records/fda_inspections/novartis-doo/2c463818-4c0e-46cb-ae7f-ccabe358fe47) — classification: No Action Indicated (NAI), source: FDA, date: August 12, 2009

## Related Companies

- [Siegfried USA, LLC](https://www.keypedia.com/companies/siegfried-usa-llc/0e21650d-f620-4e29-a62d-aa4ecd79cef2)
- [Hovione FarmaCiencia SA](https://www.keypedia.com/companies/hovione-farmaciencia-sa/e55a2dd8-7c1c-493d-8511-9761732d75ec)
- [Sparhawk Laboratories Inc](https://www.keypedia.com/companies/sparhawk-laboratories-inc/0edcf26d-ffdf-460f-b9fd-264b336000d5)
- [AbbVie Inc.](https://www.keypedia.com/companies/abbvie-inc/404ebab5-56a6-486d-bb01-be43a9478fad)
- [Fresenius Kabi Austria Gmbh](https://www.keypedia.com/companies/fresenius-kabi-austria-gmbh/f0cc0bbb-a42b-4b48-9334-0426fb359254)
- [Astellas Pharma Inc.](https://www.keypedia.com/companies/astellas-pharma-inc/9a5bc049-426d-4313-b8b8-1ce28d48fa42)
- [Indena S.p.A.](https://www.keypedia.com/companies/indena-spa/bc7187ac-74c4-4f04-bd1c-0d888424e076)
- [Viatris Pharmaceuticals LLC](https://www.keypedia.com/companies/viatris-pharmaceuticals-llc/86ee0564-73c3-4575-acbc-56fb8e87627c)
- [Sun Pharmaceutical Industries Limited](https://www.keypedia.com/companies/sun-pharmaceutical-industries-limited/51c5d6b8-303e-4e32-bbef-eaca05e879ef)
- [Vistin Pharma AS avd Kragero Fikkjebakke](https://www.keypedia.com/companies/vistin-pharma-as-avd-kragero-fikkjebakke/6acc0a66-9192-481c-a1bf-4d4d0cbf68e7)

## Related Officers

- [Bo Chi, Ph.D.](https://www.keypedia.com/people/bo-chi-phd/0016303e-704f-4a0a-ad1d-6ae4efdc1b19)
- [Michael Moses, Ph.D.](https://www.keypedia.com/people/michael-moses-phd/705eb939-be62-4d9b-bd7b-dbeb53607fc3)